Cefdinir

Cefdinir (FK-482) is a semi-synthetic, broad-spectrum antibiotic in the third generation of the cephalosporin class, which is proved to be effective for infections caused by several Gram-negative and Gram-positive bacteria. Cefdinir can be used for the research of common bacterial infections of the ear, sinus, throat, and skin[1][2].

Product Specifications

CAS Number

[91832-40-5]

Product Name Alternative

FK-482; CI-983

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Antibiotic; Bacterial

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/Cefdinir.html

Concentration

10mM

Purity

99.50

Solubility

DMSO : 33.33 mg/mL (ultrasonic)

Smiles

O=C(C(N12)=C(C=C)CS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=N\O)=O)C1=O)O

Molecular Formula

C14H13N5O5S2

Molecular Weight

395.41

Precautions

H302, H315, H319, H335

References & Citations

[1]Soejima R. Cefdinir. Jpn J Antibiot. 1992 Oct;45 (10) :1239-52.|[2]Labro MT, et al. Cefdinir (CI-983), a new oral amino-2-thiazolyl cephalosporin, inhibits human neutrophil myeloperoxidase in the extracellular medium but not the phagolysosome. J Immunol. 1994 Mar 1;152 (5) :2447-55.